Telerad Tech’s New Innovative Artificial Intelligence Product to Detect Early Stage Breast Cancer

Bangalore, Nove,mber 14, 2018: Telerad Tech, a global healthcare technology company, launched their new AI-Powered product – MammoAssist to detect early-stage breast cancer. MammoAssist was launched at “Artificial Intelligence in Radiology (AIR 2018) Symposium” organized in Bangalore amidst the presence of country’s prominent radiologists and technocrats. MammoAssist analyzes a mammogram and processes the imaging data to recognize radiologic features of early stage breast cancer and categorizes it for BIRADS Scoring with a full-fledged structured template. This template is then made available to a radiologist who corroborates/validates the mammography findings and issues the official report.

As per the Ministry of Health and Family Welfare (MoHFW), breast cancer is the most common cancer among Indian females with an incidence of 25.8 per 100,000 women with 50% survival rate – the primary reason of mortality is late detection. Governments in India and globally are under huge pressure to improve this situation in a cost-effective manner. MammoAssist is an economical solution addressing the need for early detection of breast cancer. It acts as a catalyst for the radiologist to review mammograms in minimal time and reducing the costs of mass screening programs.

“In breast cancer, early detection is of paramount importance in terms of improving patient outcome and reducing healthcare costs. Today, in India, most breast cancer cases are unfortunately diagnosed at a late stage, in part due to the shortage of radiologists required for interpretation of mammograms for the early detection of breast cancer. MammoAssist has the potential to be a game changer in terms of assisting radiologists and facilitating early detection of breast cancer,” explains Dr. Arjun Kalyanpur, Founder & Chief Radiologist of Teleradiology Solutions & Telerad Tech.

Mr. Prashant Akhawat, COO of Telerad Tech says, “MammoAssist can play a significant role in breast cancer screening programs to eliminate negative cases with a high degree of accuracy and categorizing benign and malignant cases with a fully structured report with BIRADS Score in multiple languages. Our studies have shown that MammoAssist can improve the efficiency and productivity of a radiologist by more than 50%. We are highly committed to improving patient care through artificial intelligence and deep learning in the clinical environment.”

MammoAssist generates a detailed report with all significant radiologic findings such as Microcalcification, Macrocalcification, Clustered Calcification, Lesions & Lymph Node, Architectural Distortion, Bilateral Asymmetry, Breast Parenchymal Composition, Size, Shape, Location and Density analysis with BI-RADS (Breast Imaging Reporting and Data System) score. It enhances the ability of a radiologist to report cases with high accuracy and efficiency and provides a standard interface to communicate with healthcare systems like RIS-PACS, EMRs through industry standard API and protocols. MammoAssist can generate reports in multiple languages including English, Spanish, German, French, Italian, Polish, and Portuguese.

MammoAssist powers Telerad Tech’s Next Generation AI Enabled RIS-PACS Platform RADSpa, which is FDA approved and CE certified.

Corporate Comm India(CCI NewsWire)